The Research and Development team at Stallergenes Greer focuses on innovating and advancing Allergy Immunotherapy products to enhance the treatment of respiratory allergies. This multidisciplinary team collaborates on scientific research, evaluates therapeutic advancements, ensures compliance with medical regulations, and manages portfolios to bring new therapies from concept to market. Their work is crucial in improving patient outcomes and maintaining the company’s leadership in allergy management.
View all